Prevalence, patterns and factors associated with multiple medicines use in an ageing poulation with intelletual disability in Ireland

Abstract

The provision of rational and appropriate pharmacotherapy to older people with intellectual disabilities (ID) poses significant challenges due to the complexities of conditions being treated, the increased risks of adverse drug reactions, and the challenges associated with communication and atypical disease presentation. People with intellectual disabilities are often prescribed medicines to treat a variety of chronic conditions and are likely to be exposed to polypharmacy. Life expectancy for people with ID is increasing in Ireland and elsewhere. Little research has been carried out to date assessing patterns of multiple medicine use in an ageing population with ID.